EA200870263A1 - INTRAVENOUS METHOD OF TREATING VIRAL INFECTION - Google Patents

INTRAVENOUS METHOD OF TREATING VIRAL INFECTION

Info

Publication number
EA200870263A1
EA200870263A1 EA200870263A EA200870263A EA200870263A1 EA 200870263 A1 EA200870263 A1 EA 200870263A1 EA 200870263 A EA200870263 A EA 200870263A EA 200870263 A EA200870263 A EA 200870263A EA 200870263 A1 EA200870263 A1 EA 200870263A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treating viral
viral infection
intravenous method
intravenous
treating
Prior art date
Application number
EA200870263A
Other languages
Russian (ru)
Other versions
EA025483B1 (en
Inventor
Ярлагадда Судхакара Бабу
Пооран Чанд
Шанта Бантиа
Шейн Арнольд
Джон Майкл Килпатрик
Original Assignee
Байокрист Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200870263(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/en
Application filed by Байокрист Фармасьютикалз, Инк. filed Critical Байокрист Фармасьютикалз, Инк.
Publication of EA200870263A1 publication Critical patent/EA200870263A1/en
Publication of EA025483B1 publication Critical patent/EA025483B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

В настоящем изобретении предложены стандартные лекарственные формы, наборы и способы, применимые для лечения вирусных инфекций.The present invention provides unit dosage forms, kits, and methods useful for treating viral infections.

EA200870263A 2006-02-13 2007-02-12 Intravenous method for treating a seasonal influenza EA025483B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments
PCT/US2007/003755 WO2007095218A1 (en) 2006-02-13 2007-02-12 Intravenous antiviral treatments

Publications (2)

Publication Number Publication Date
EA200870263A1 true EA200870263A1 (en) 2009-06-30
EA025483B1 EA025483B1 (en) 2016-12-30

Family

ID=38169715

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870263A EA025483B1 (en) 2006-02-13 2007-02-12 Intravenous method for treating a seasonal influenza

Country Status (11)

Country Link
EP (1) EP1986626A1 (en)
JP (3) JP2009538822A (en)
KR (9) KR102475176B1 (en)
AU (2) AU2007215156A1 (en)
BR (1) BRPI0707769A2 (en)
CA (1) CA2642260C (en)
EA (1) EA025483B1 (en)
HK (1) HK1212250A1 (en)
MX (2) MX2008010394A (en)
MY (1) MY166063A (en)
WO (1) WO2007095218A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102475176B1 (en) * 2006-02-13 2022-12-07 바이오크리스트 파마수티컬즈, 인코퍼레이티드 Intravenous antiviral treatments
CN101367750B (en) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1S,2S,3S,4R)-3-[(1S)-1-acet-ammonia-2-ethyl-butyl]-4- guanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid aqua compound and medical uses thereof
KR20220033561A (en) 2020-09-07 2022-03-17 주식회사 경보제약 Pharmaceutical composition of premix formulation containing peramivir compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU723360B2 (en) * 1996-06-14 2000-08-24 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane compounds useful as neuraminidase inhibitors
ATE425955T1 (en) * 1997-12-17 2009-04-15 Biocryst Pharm Inc SUBSTITUTED CYCLOPENTAN AND CYCLOPENTEN COMPOUNDS AS NEURAMINIDASE BLOCKERS
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
KR102475176B1 (en) * 2006-02-13 2022-12-07 바이오크리스트 파마수티컬즈, 인코퍼레이티드 Intravenous antiviral treatments

Also Published As

Publication number Publication date
KR102267754B1 (en) 2021-06-23
KR20140132778A (en) 2014-11-18
JP2009538822A (en) 2009-11-12
EP1986626A1 (en) 2008-11-05
KR20190072681A (en) 2019-06-25
CA2642260C (en) 2016-08-09
AU2007215156A1 (en) 2007-08-23
JP2015180695A (en) 2015-10-15
MX2020002008A (en) 2020-07-13
MY166063A (en) 2018-05-23
EA025483B1 (en) 2016-12-30
KR20200143519A (en) 2020-12-23
KR20160129105A (en) 2016-11-08
KR101992585B9 (en) 2022-09-20
JP2013256527A (en) 2013-12-26
KR102475176B1 (en) 2022-12-07
KR20230003248A (en) 2023-01-05
KR102323339B1 (en) 2021-11-08
CA2642260A1 (en) 2007-08-23
KR101992585B1 (en) 2019-06-25
BRPI0707769A2 (en) 2011-05-10
KR20210076189A (en) 2021-06-23
HK1212250A1 (en) 2016-06-10
WO2007095218A1 (en) 2007-08-23
KR20180024027A (en) 2018-03-07
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
MX2008010394A (en) 2009-01-12
KR20210135632A (en) 2021-11-15
KR102194015B1 (en) 2020-12-22
KR20080096829A (en) 2008-11-03
JP6073202B2 (en) 2017-02-01

Similar Documents

Publication Publication Date Title
EA201071315A1 (en) HEPATITIS C VIRUS PROTEASE INHIBITORS
MA33806B1 (en) INHIBITORS OF HEPATITIS C VIRUS
EA200900298A1 (en) HEPATITIS C VIRUS INHIBITORS
EA200971077A1 (en) HETEROCYCLIC KINASE MODULATORS
EA200802182A1 (en) MODIFIED HUMANIZED ANTIBODIES AGAINST INTERLEUKIN-18
EA201170212A1 (en) COOLING AND TREATMENT OF MATERIALS
EA201070247A1 (en) PROTEAS INHIBITORS
EA200900802A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
CL2011002426A1 (en) Compounds derived from substituted benzo-diazole pyrrolidine, inhibitors of the function of the ns5a protein encoded by the hepatitis c virus (vhc); pharmaceutical composition; and its use for the treatment of a vhc infection.
CL2011000838A1 (en) Heterocyclic compounds derived from ortho-condensed tetracycles with a pyrimidine 2,4,6-trione spirocondensate group, bacterial DNA gyrase inhibitors; Preparation process; pharmaceutical composition; and its use for the treatment of a bacterial infection.
EA201390190A1 (en) HEPATITIS C VIRUS INHIBITORS
EA200901078A1 (en) Conjugates of Synthetic Agonists TLR and Their Use
EA200600078A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
EA200702048A1 (en) PHARMACOKINETICALLY IMPROVED COMPOUNDS
BRPI0612124A2 (en) heteroaryl derivatives for the treatment of viruses
EA200970805A1 (en) SERINPROTEAS INHIBITORS FOR THE TREATMENT OF HCV INFECTIONS
EA200901241A1 (en) CONNECTIONS FOR THE TREATMENT OF HEPATITIS C
EA200971096A1 (en) THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
NO20064547L (en) Methods for treating HIV infection
ATE497492T1 (en) CLEANING MONTELUKAST
WO2008115281A3 (en) Compounds for treating viral infections
DE602005012481D1 (en) 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8- (1H-INDOL-5-YL) -OCTANAMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF BLOOD HIGH PRESSURE
EA201000895A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES
EA201000948A1 (en) VIRAL POLYMERASE INHIBITORS